Chemnovatic Joins GINN: Leading the Way in Nicotine Innovation and Regulation

Chemnovatic is proud to announce our membership in the Global Institute for Novel Nicotine (GINN) – an international organization uniting manufacturers, scientists, and regulators to support the development of reduced-risk nicotine products such as nicotine pouches and other non-combustible alternatives.

This partnership is more than a formal affiliation – it is a strategic step in reinforcing our role as a trusted B2B nicotine solutions supplier. As a member of GINN, we gain direct access to industry-wide discussions on the Tobacco Products Directive (TPD3) and the Tobacco Excise Directive (TED) revisions.

This means:

• Proactive compliance – anticipating changes before they impact the market,
• Advocacy for fair, risk-proportionate policies that recognize the harm-reduction potential of novel nicotine products,
• Commitment to safety and quality, backed by EP/USP standards and rigorous distillation processes,
• Sustainable growth, supporting a transparent, responsible nicotine industry.

For our partners, this translates into earlier insights, stable supply chains, and formulations designed to meet the highest regulatory and quality requirements.

In a sector facing increasing regulatory uncertainty and public misconceptions, GINN plays a crucial role in ensuring that EU policies are evidence-based, proportionate to risk, and supportive of innovation. Without clear distinctions between product categories, reduced-risk alternatives could be subject to the same rules as combustible tobacco – limiting harm reduction potential.

By joining GINN, Chemnovatic is taking an active role in shaping regulation, not just following it. Together, we advocate for:
✅ Clear, product-specific regulations under TPD3
✅ Fair, risk-proportionate taxation under TED
✅ Sustainable innovation with high-quality, compliant formulations
✅ Transparent, science-driven public health communication

GINN membership reinforces our mission to be the first choice in nicotine technologies for organizations driving the global shift towards a sustainable, smoke-free future. Through constant research and development, we deliver nicotine and derivatives of the highest purity, meeting the strictest quality standards, and ensuring full regulatory compliance. Partner with us to secure a reliable, future-ready nicotine supply chain – contact our team today to discuss how we can support your business.